Maria Lourdes Farre Vallve - Desvinculada
Português, Brasil
Possui graduação em Graduação em Química - Universidad de Barcelona (1994) e doutorado em Bioquimica - Universidad de Barcelona (2002). Atualmente é pesquisadora em saúde pública do Centro de Pesquisas Gonçalo Moniz (CPqGM/FIOCRUZ/Ba) e bolsista de produtividade nível 2 do CNPq. Também é professora permanente da Pós-graduação em Biotecnologia e Medicina Investigativa do CPqGM. Tem experiência na área de biologia molecular e celular, com ênfase em oncologia molecular, atuando principalmente em linfomas cutâneos com enfase em leucemia/linfoma das células T do adulto e nas doenças associadas ao HTLV-1 na faixa infanto-juvenil. Também coordena projetos que visam promover o cuidado em saúde em comunidades rurais e divulgar os aspectos clínicos e sociais relacionados com a infecção pelo HTLV-1.
Titulação:
Doutor em Bioquimica
Vínculo:
Permanente
Email:
Telefone:
71. 31762228
Currículo Lattes:
Orientando:
Produção Científica:
- Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumor.
- A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients.
- Adult T-cell leukemia/lymphoma - 2016
- Assessment of genetic diversity of HTLV-1 ORF-I sequences collected from patients with different clinical profiles
- Clinicopathological aspects and proviral load of adulthood infective dermatitis associated with HTLV-1: Comparison between juvenile and adulthood forms.
- Complete genome sequence of human T-cell lymphotropic type 1 from patients with different clinical profiles, including infective dermatitis.
- Decreased RORC expression and downstream signaling in HTLV-1-associated Adult T-cell Lymphoma/Leukemia uncovers an antiproliferative IL17 link: a potential target for immunotherapy?.
- Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?.
- Early Juvenile Human T-cell Lymphotropic Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Study of 25 Patients.
- Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer - 2016
- Epigenetic Loss of m1A RNA Demethylase ALKBH3 in Hodgkin Lymphoma Targets Collagen Conferring Poor Clinical Outcome.
- Microsatellite Alterations Are also Present in the Less Aggressive Types of Adult T-Cell Leukemia-Lymphoma - 2015
- Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours.
- Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.
- The transcribed pseudogene RPSAP52 enhances the oncofetal HMGA2-IGF2BP2-RAS axis through LIN28B-dependent and independent let-7 inhibition.
